Pharmaceutical
Cannabis M&A, lounging in the future and an LSE downturn
Ripe for the Picking | Cannabis M&A predictions for 2022 Low stock prices are likely to motivate more cannabis mergers and acquisitions in 2022, reports Insider.
booker
8stories
13 Declast updated
More in booker
- CBD Market
Should CBD regulations come before cannabis reform?
Since broader federal cannabis reform could take quite some time, the Natural Products Association (NPA) penned an op-ed for Marijuana Moment reminding regulators that CBD, while legal, is still woefully under-regulated — and that it should be prioritized first.
- Hemp Industry
Schumer’s cannabis bill would end prohibition
Senators Chuck Schumer, Cory Booker and Ron Wyden held a press conference yesterday to introduce their draft bill of the Cannabis Administration and Opportunity Act.
- Adult-Use
Will midterms mess up US legalization?
Canadian LPs are banking on federal legalization in the US, but some are worried that it won’t happen before the 2022 midterm elections, when Democrats could lose control of Congress to Republicans, according to a Canadian Press report.
- Uncategorized
What’s better than a Super Bowl?
Good morning. Today is another post-Tom Brady Super Bowl Monday… Last week was a busy week one in cannabis last week – with a major acquisition and more (and more) US states looking toward legalization.
